Overview
Kevin Yee is a Hematologist in Tualatin, Oregon. Dr. Yee is rated as an Experienced provider by MediFind in the treatment of Primary Amyloidosis. His top areas of expertise are Neuroendocrine Tumor, Paget Disease of the Breast, Pleuropulmonary Blastoma, and Lung Cancer.
His clinical research consists of co-authoring 3 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- POS
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- PPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
19260 SW 65th Ave Ste 140, Tualatin, OR 97062
15700 SW Greystone Ct, Beaverton, OR 97006
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
OHSU Hospital
Eva Medvedova is a Hematologist in Portland, Oregon. Dr. Medvedova is rated as a Distinguished provider by MediFind in the treatment of Primary Amyloidosis. Her top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.
OHSU Hospital
Emma Scott is a Hematologist in Portland, Oregon. Dr. Scott is rated as an Advanced provider by MediFind in the treatment of Primary Amyloidosis. Her top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Primary Amyloidosis, Bone Marrow Transplant, and Bone Marrow Aspiration.
OHSU Hospital
Richard Maziarz is a Hematologist in Portland, Oregon. Dr. Maziarz is rated as a Distinguished provider by MediFind in the treatment of Primary Amyloidosis. His top areas of expertise are B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Marrow Aspiration.
Frequently Asked Questions about Dr. Kevin Yee
How do I make an appointment with Dr. Kevin Yee?
You can book an appointment with Dr. Kevin Yee by calling their office at 503-203-1000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Kevin Yee a top-rated expert for Neuroendocrine Tumor?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kevin Yee is classified as an Distinguished expert for Neuroendocrine Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Kevin Yee specialize in?
While Dr. Kevin Yee is a Hematology, they have specific expertise in Neuroendocrine Tumor, Paget Disease of the Breast, and Pleuropulmonary Blastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Kevin Yee participate in research or clinical trials?
Yes. Dr. Kevin Yee has published 3 articles and abstracts on conditions like Neuroendocrine Tumor. You can view a list of Dr. Kevin Yee's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Kevin Yee accept my insurance?
Dr. Kevin Yee accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 503-203-1000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerDr. Yee isDistinguished. Learn about Lung Cancer.
- Neuroendocrine TumorDr. Yee isDistinguished. Learn about Neuroendocrine Tumor.
- Paget Disease of the BreastDr. Yee isDistinguished. Learn about Paget Disease of the Breast.
- Pleuropulmonary BlastomaDr. Yee isDistinguished. Learn about Pleuropulmonary Blastoma.
- Advanced
- Adult Soft Tissue SarcomaDr. Yee isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Ataxia-Pancytopenia Syndrome
- Autoimmune Hemolytic AnemiaDr. Yee isAdvanced. Learn about Autoimmune Hemolytic Anemia.
- Breast CancerDr. Yee isAdvanced. Learn about Breast Cancer.
- Childhood Iron Deficiency Anemia
- Chronic B-Cell Leukemia (CBCL)
- Experienced
- Acute Mountain SicknessDr. Yee isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Yee isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisDr. Yee isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer